Volume 69, Issue 6, Pages (June 2016)

Slides:

Advertisements

Similar presentations

Volume 60, Issue 5, Pages (November 2011)

Advertisements

Volume 51, Issue 2, Pages (February 2007)

The Origin of the Bone Scan as a Tumour Marker in Prostate Cancer

Volume 66, Issue 6, Pages (December 2014)

European Urology Focus

Global Trends in Testicular Cancer Incidence and Mortality

Volume 58, Issue 1, Pages (July 2010)

Volume 52, Issue 5, Pages (November 2007)

Volume 60, Issue 2, Pages (August 2011)

European Urology Oncology

Volume 66, Issue 1, Pages (July 2014)

Volume 63, Issue 4, Pages (April 2013)

Volume 53, Issue 5, Pages (May 2008)

Lymphadenectomy in the Surgical Management of Penile Cancer

Volume 69, Issue 1, Pages (January 2016)

Volume 60, Issue 5, Pages (November 2011)

Volume 63, Issue 3, Pages e39-e40 (March 2013)

Volume 53, Issue 5, Pages (May 2008)

Let the Games Begin (with EAU Approval)

Prostate Cancer Epidemic in Sight?

Volume 52, Issue 4, Pages (October 2007)

Volume 64, Issue 4, Pages (October 2013)

Volume 59, Issue 2, Pages (February 2011)

Volume 63, Issue 1, Pages (January 2013)

Volume 64, Issue 4, Pages (October 2013)

The Global Risk of Bladder Cancer: Let's Just Do Something About It!

The Importance of Transurethral Resection in Managing Patients With Urothelial Cancer in the Bladder: Proposal for a Transurethral Resection of Bladder.

Volume 68, Issue 5, Pages (November 2015)

Volume 61, Issue 5, Pages (May 2012)

Volume 61, Issue 4, Pages (April 2012)

Ute Ganswindt, Arnulf Stenzl, Michael Bamberg, Claus Belka

Volume 61, Issue 6, Pages (June 2012)

Volume 71, Issue 5, Pages (May 2017)

Volume 69, Issue 3, Pages (March 2016)

Volume 64, Issue 3, Pages (September 2013)

Volume 57, Issue 4, Pages e41-e42 (April 2010)

Volume 71, Issue 6, Pages (June 2017)

Volume 49, Issue 6, Pages (June 2006)

Prostate Cancer Epidemic in Sight?

James N. Armitage, Stuart O. Irving, Neil A. Burgess European Urology

Volume 71, Issue 6, Pages (June 2017)

Stephen B. Williams, Ashish M

The Origin of the Bone Scan as a Tumour Marker in Prostate Cancer

Volume 53, Issue 6, Pages (June 2008)

Volume 66, Issue 6, Pages (December 2014)

Volume 66, Issue 6, Pages (December 2014)

Volume 61, Issue 2, Pages (February 2012)

Volume 63, Issue 3, Pages (March 2013)

Long-term Cancer-specific Survival in Patients with High-risk, Non–muscle-invasive Bladder Cancer and Tumour Progression: A Systematic Review Sven van.

Shifting Paradigms for High-grade Prostatic Intraepithelial Neoplasia

Volume 71, Issue 1, Pages (January 2017)

Volume 60, Issue 6, Pages (December 2011)

Might Men Diagnosed with Metastatic Prostate Cancer Benefit from Definitive Treatment of the Primary Tumor? A SEER-Based Study Stephen H. Culp, Paul.

The Economic Costs of Overactive Bladder in Germany

Volume 53, Issue 1, Pages (January 2008)

Adjuvant Chemotherapy with 5-Fluorouracil and Cisplatin in Lymph Node-Positive Thoracic Esophageal Squamous Cell Carcinoma Jeeyun Lee, MD, Kyoung-Eun.

Volume 62, Issue 3, Pages (September 2012)

Volume 50, Issue 5, Pages (November 2006)

Volume 71, Issue 5, Pages (May 2017)

Volume 74, Issue 4, Pages (October 2018)

Volume 59, Issue 4, Pages (April 2011)

Prognostic Impact of Comorbidity in Patients with Bladder Cancer

European Urology is “Your” Journal

Georges-Pascal Haber, Sebastien Crouzet, Inderbir S. Gill

Volume 52, Issue 4, Pages (October 2007)

Early Single-Instillation Chemotherapy Has No Real Benefit and Should Be Abandoned in Non–Muscle-Invasive Bladder Cancer Sten Holmäng European Urology.

Volume 51, Issue 2, Pages (February 2007)

Penile and Testicular Cancer: What's New in 2006?

Volume 54, Issue 1, Pages (July 2008)

Volume 51, Issue 5, Pages (May 2007)

Presentation transcript:

Volume 69, Issue 6, Pages 984-987 (June 2016) Decreased Overall and Bladder Cancer–Specific Mortality with Adjuvant Chemotherapy After Radical Cystectomy: Multivariable Competing Risk Analysis Michael Froehner, Rainer Koch, Ulrike Heberling, Vladimir Novotny, Sven Oehlschlaeger, Matthias Hübler, Gustavo B. Baretton, Oliver W. Hakenberg, Manfred P. Wirth European Urology Volume 69, Issue 6, Pages 984-987 (June 2016) DOI: 10.1016/j.eururo.2015.06.053 Copyright © 2015 European Association of Urology Terms and Conditions

Fig. 1 Cumulative bladder cancer–specific mortality curves stratified by application of adjuvant cisplatin-based chemotherapy in the whole study sample and in patients with positive lymph nodes and extravesical lymph node–negative disease, respectively (univariate competing risk analysis). European Urology 2016 69, 984-987DOI: (10.1016/j.eururo.2015.06.053) Copyright © 2015 European Association of Urology Terms and Conditions